نتائج البحث - "желчнокаменная болезнь"

المصدر: World of Medicine : Journal of Biomedical Sciences; Vol. 1 No. 11 (2024): World of Medicine : Journal of Biomedical Sciences; 180-185 ; 2960-9356

مصطلحات موضوعية: Желчнокаменная болезнь, холецистохоледохолитиаз, гибридная, операция

وصف الملف: application/pdf

Relation: https://wom.semanticjournals.org/index.php/biomed/article/view/188/165; https://wom.semanticjournals.org/index.php/biomed/article/view/188

الاتاحة: https://wom.semanticjournals.org/index.php/biomed/article/view/188

View record in BASE

4

Academic Journal

FEATURES OF THE DEVELOPMENT OF ARTHRITIS AND ARTHRITIS IN DISEASES OF THE GALLBLADDER ; O‘T PUFAGI KASALLIKLARIDA ARTRIT VA ARTROZNING RIVOJLANISH XUSUSIYATLARI ; ОСОБЕННОСТИ РАЗВИТИЯ АРТРИТОВ И АРТРИТОВ ПРИ ЗАБОЛЕВАНИЯХ ЖЕЛЧНОГО ПУЗЫРЯ

المؤلفون: Bekkulova , Mohigul

المصدر: Eurasian Journal of Medical and Natural Sciences; Vol. 4 No. 12 (2024): Eurasian Journal of Medical and Natural Sciences; 20-23 ; Евразийский журнал медицинских и естественных наук; Том 4 № 12 (2024): Евразийский журнал медицинских и естественных наук; 20-23 ; Yevrosiyo tibbiyot va tabiiy fanlar jurnali; Jild 4 Nomeri 12 (2024): Yevrosiyo tibbiyot va tabiiy fanlar jurnali; 20-23 ; 2181-287X

مصطلحات موضوعية: Artrit, artroz, xolesistit, xolelitiaz, degenirativ, Arthritis, osteoarthritis, cholecystitis, cholelithiasis, degenerative, Артрит, артроз, холецистит, желчнокаменная болезнь, дегенеративный

وصف الملف: application/pdf

Relation: https://in-academy.uz/index.php/EJMNS/article/view/40858/26003

الاتاحة: https://in-academy.uz/index.php/EJMNS/article/view/40858

View record in BASE

5

Academic Journal

ПРЕИМУЩЕСТВА ОДНОЭТАПНОЙ ЛАПАРОЭНДОСКОПИЧЕСКОЙ КОРРЕКЦИИ ХОЛЕЦИСТОХОЛЕДОХОЛИТИАЗА

المؤلفون: Пулат, АСКАРОВ

المصدر: 2(5), 4-12, (2024-09-08)

مصطلحات موضوعية: желчнокаменная болезнь, холедохолитиаз, холецистэктомия, холедохолитоэкстракция, папиллосфинктеротомия, техника Rendezvous, лапароэндоскопическое рандеву

Relation: https://zenodo.org/communities/imfaktorpages; https://doi.org/10.5281/zenodo.13731748; https://doi.org/10.5281/zenodo.13731749; oai:zenodo.org:13731749

الاتاحة: https://doi.org/10.5281/zenodo.13731749

View record in BASE

6

Academic Journal

Reduction of the risk of biliary lithiasis caused by various weight reduction options in obesity ; Снижение риска билиарного литиаза на фоне различных вариантов редукции веса при ожирении

المؤلفون: E. Yu. Plotnikova, A. S. Sukhikh, Е. Ю. Плотникова, А. С. Сухих

المصدر: Meditsinskiy sovet = Medical Council; № 15 (2024); 114–124 ; Медицинский Совет; № 15 (2024); 114–124 ; 2658-5790 ; 2079-701X

مصطلحات موضوعية: урсодезоксихолевая кислота, cholelithiasis, biliary tract, bariatric surgery, ursodeoxycholic acid, желчнокаменная болезнь, билиарный тракт, бариатрическая хирургия

وصف الملف: application/pdf

Relation: https://www.med-sovet.pro/jour/article/view/8578/7533; Portincasa P, Di Ciaula A, Bonfrate L, Stella A, Garruti G, Lamont JT. Metabolic dysfunction-associated gallstone disease: expecting more from critical care manifestations. Intern Emerg Med. 2023;18(7):1897–1918. https://doi.org/10.1007/s11739-023-03355-z.; Everhart JE, Ruhl CE. Burden of digestive diseases in the United States Part III: Liver, biliary tract, and pancreas. Gastroenterology. 2009;136(4):1134–1144. https://doi.org/10.1053/j.gastro.2009.02.038.; Portincasa P, Ciaula AD, Bonfrate L, Wang DQ. Therapy of gallstone disease: What it was, what it is, what it will be. World J Gastrointest Pharmacol Ther. 2012;3(2):7–20. https://doi.org/10.4292/wjgpt.v3.i2.7.; Attili AF, De Santis A, Capri R, Repice AM, Maselli S. The natural history of gallstones: the GREPCO experience. The GREPCO Group. Hepatology. 1995;21(3):655–660. https://doi.org/10.1002/hep.1840210309.; Schafmayer C, Hartleb J, Tepel J, Albers S, Freitag S, Völzke H et al. Predictors of gallstone composition in 1025 symptomatic gallstones from Northern Germany. BMC Gastroenterol. 2006;6:36. https://doi.org/10.1186/1471-230X-6-36.; Wang X, Bai Y, Yu W, Xie L, Li S, Jiang G et al. New Progress in Longitudinal Research on the Risk Factors for Cholelithiasis. Sichuan Da Xue Xue Bao Yi Xue Ban. 2024;55(2):490–500. (In Chinese.) https://doi.org/10.12182/20240360508.; Katsika D, Grjibovski A, Einarsson C, Lammert F, Lichtenstein P, Marschall HU. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. Hepatology. 2005;41(5):1138–1143. https://doi.org/10.1002/hep.20654.; Lammert F, Sauerbruch T. Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol Hepatol. 2005;2(9):423–433. https://doi.org/10.1038/ncpgasthep0257.; Lammert F, Miquel JF. Gallstone disease: from genes to evidence-based therapy. J Hepatol. 2008;48(Suppl. 1):124–135. https://doi.org/10.1016/j.jhep.2008.01.012.; Wang DQ, Zhang L, Wang HH. High cholesterol absorption efficiency and rapid biliary secretion of chylomicron remnant cholesterol enhance cholelithogenesis in gallstone-susceptible mice. Biochim Biophys Acta. 2005;1733(1):90–99. https://doi.org/10.1016/j.bbalip.2004.12.005.; Wittenburg H, Lammert F. Genetic predisposition to gallbladder stones. Semin Liver Dis. 2007;27(1):109–121. https://doi.org/10.1055/s-2006-960174.; Lammert F, Gurusamy K, Ko CW, Miquel JF, Méndez-Sánchez N, Portincasa P et al. Gallstones. Nat Rev Dis Primers. 2016;2:16024. https://doi.org/10.1038/nrdp.2016.24.; Li VK, Pulido N, Fajnwaks P, Szomstein S, Rosenthal R, Martinez-Duartez P. Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy. Surg Endosc. 2009;23(7):1640–1644. https://doi.org/10.1007/s00464-008-0204-6.; Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Weight cycling and risk of gallstone disease in men. Arch Intern Med. 2006;166(21):2369–2374. https://doi.org/10.1001/archinte.166.21.2369.; Stokes CS, Lammert F. Excess Body Weight and Gallstone Disease. Visc Med. 2021;37(4):254–260. https://doi.org/10.1159/000516418.; Stender S, Nordestgaard BG, Tybjaerg-Hansen A. Elevated body mass index as a causal risk factor for symptomatic gallstone disease: a Mendelian randomization study. Hepatology. 2013;58(6):2133–2141. https://doi.org/10.1002/hep.26563.; Banim PJ, Luben RN, Bulluck H, Sharp SJ, Wareham NJ, Khaw KT, Hart AR. The aetiology of symptomatic gallstones quantification of the effects of obesity, alcohol and serum lipids on risk. Epidemiological and biomarker data from a UK prospective cohort study (EPIC-Norfolk). Eur J Gastroenterol Hepatol. 2011;23(8):733–740. https://doi.org/10.1097/MEG.0b013e3283477cc9.; Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(Suppl. 2):102–138. https://doi.org/10.1161/01.cir.0000437739.71477.ee.; Weinsier RL, Ullmann DO. Gallstone formation and weight loss. Obes Res. 1993;1(1):51–56. https://doi.org/10.1002/j.1550-8528.1993.tb00008.x.; Tsunoda K, Shirai Y, Hatakeyama K. Prevalence of cholesterol gallstones positively correlates with per capita daily calorie intake. Hepatogastroenterology. 2004;51(59):1271–1274.; Broomfield PH, Chopra R, Sheinbaum RC, Bonorris GG, Silverman A, Schoenfield LJ, Marks JW. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight. N Engl J Med. 1988;319(24):1567–1572. https://doi.org/10.1056/NEJM198812153192403.; Weinsier RL, Wilson LJ, Lee J. Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation. Am J Med. 1995;98(2):115–117. https://doi.org/10.1016/S0002-9343(99)80394-5.; Shiffman ML, Kaplan GD, Brinkman-Kaplan V, Vickers FF. Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very-low-calorie diet program. Ann Intern Med. 1995;122(12):899–905. https://doi.org/10.7326/0003-4819-122-12-199506150-00002.; Marks JW, Bonorris GG, Albers G, Schoenfield LJ. The sequence of biliary events preceding the formation of gallstones in humans. Gastroenterology. 1992;103(2):566–570. https://doi.org/10.1016/0016-5085(92)90848-s.; Kamrath RO, Plummer LJ, Sadur CN, Adler MA, Strader WJ, Young RL, Weinstein RL. Cholelithiasis in patients treated with a very-low-calorie diet. Am J Clin Nutr. 1992;56(1 Suppl.):255S-257S. https://doi.org/10.1093/ajcn/56.1.255S.; Liddle RA, Goldstein RB, Saxton J. Gallstone formation during weightreduction dieting. Arch Intern Med. 1989;149(8):1750–1753. Available at: https://pubmed.ncbi.nlm.nih.gov/2669662.; Johansson K, Sundström J, Marcus C, Hemmingsson E, Neovius M. Risk of symptomatic gallstones and cholecystectomy after a very-low-calorie diet or low-calorie diet in a commercial weight loss program: 1-year matched cohort study. Int J Obes (Lond). 2014;38(2):279–284. https://doi.org/10.1038/ijo.2013.83.; Festi D, Colecchia A, Orsini M, Sangermano A, Sottili S, Simoni P et al. Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well). Int J Obes Relat Metab Disord. 1998;22(6):592–600. https://doi.org/10.1038/sj.ijo.0800634.; Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Long-chain saturated fatty acids consumption and risk of gallstone disease among men. Ann Surg. 2008;247(1):95–103. https://doi.org/10.1097/SLA.0b013e31815792c2.; Syngal S, Coakley EH, Willett WC, Byers T, Williamson DF, Colditz GA. Longterm weight patterns and risk for cholecystectomy in women. Ann Intern Med. 1999;130(6):471–477. https://doi.org/10.7326/0003-4819-130-6-199903160-00003.; Gebhard RL, Prigge WF, Ansel HJ, Schlasner L, Ketover SR, Sande D et al. The role of gallbladder emptying in gallstone formation during diet-induced rapid weight loss. Hepatology. 1996;24(3):544–548. https://doi.org/10.1002/hep.510240313.; Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet. 2006;368(9531):230–239. https://doi.org/10.1016/S0140-6736(06)69044-2.; Shiffman ML, Sugerman HJ, Kellum JM, Moore EW. Changes in gallbladder bile composition following gallstone formation and weight reduction. Gastroenterology. 1992;103(1):214–221. https://doi.org/10.1016/0016-5085(92)91115-k.; Плотникова ЕЮ. Колпинский ГИ, Семенчук ИН, Краснов КА. Гастроэнтерологические проблемы бариатрической хирургии. Клинический разбор в общей медицине. 2023;4(8):83–92. https://doi.org/10.47407/kr2023.4.8.00335.; Gustafsson U, Benthin L, Granström L, Groen AK, Sahlin S, Einarsson C. Changes in gallbladder bile composition and crystal detection time in morbidly obese subjects after bariatric surgery. Hepatology. 2005;41(6):1322–1328. https://doi.org/10.1002/hep.20686.; Stampfer MJ, Maclure KM, Colditz GA, Manson JE, Willett WC. Risk of symptomatic gallstones in women with severe obesity. Am J Clin Nutr. 1992;55(3):652–658. https://doi.org/10.1093/ajcn/55.3.652.; Bastouly M, Arasaki CH, Ferreira JB, Zanoto A, Gouveia F, Borges HP, Del Grande JC. Early Changes in Postprandial Gallbladder Emptying in Morbidly Obese Patients Undergoing Roux-en-Y Gastric Bypass: Correlation with the Occurrence of Biliary Sludge and Gallstones. Obes Surg. 2009;19:22–28. https://doi.org/10.1007/s11695-008-9648-y.; Worobetz LJ, Inglis FG, Shaffer EA. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss. Am J Gastroenterol. 1993;88(10):1705–1710.; Adams LB, Chang C, Pope J, Kim Y, Liu P, Yates A. Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve Gastrectomy. Obes Surg. 2015;26:990–994. https://doi.org/10.1007/s11695-015-1858-5.; Nabil TM, Khalil AH, Gamal K. Effect of oral ursodeoxycholic acid on cholelithiasis following laparoscopic sleeve gastrectomy for morbid obesity. Surg Obes Relat Dis. 2019;15:827–831. https://doi.org/10.1016/j.soard.2019.03.028.; Sakran N, Dar R, Assalia A, Neeman Z, Farraj M, Sherf-Dagan S et al. The use of Ursolit for gallstone prophylaxis following bariatric surgery: A randomized-controlled trial. Updat Surg. 2020;72:1125–1133. https://doi.org/10.1007/s13304-020-00850-2.; Altieri MS, Yang J, Nie L, Docimo S, Talamini M, Pryor AD. Incidence of cholecystectomy after bariatric surgery. Surg Obes Relat Dis. 2018;14:992–996. https://doi.org/10.1016/j.soard.2018.03.028.; Coupaye M, Calabrese D, Sami O, Msika S, Ledoux S. Evaluation of incidence of cholelithiasis after bariatric surgery in subjects treated or not treated with ursodeoxycholic acid. Surg Obes Relat Dis. 2017;13:681–685. https://doi.org/10.1016/j.soard.2016.11.022.; Portenier DD, Grant JP, Blackwood HS, Pryor A, McMahon RL, DeMaria E. Expectant management of the asymptomatic gallbladder at Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2007;3:476–479. https://doi.org/10.1016/j.soard.2007.02.006.; Miller K, Hell E, Lang B, Lengauer E. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial. Ann Surg. 2003;238(5):697–702. https://doi.org/10.1097/01.sla.0000094305.77843.cf.; Haal S, Guman MSS, Boerlage TCC, Acherman YIZ, de Brauw LM, Bruin S et al. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial. Lancet Gastroenterol Hepatol. 2021;6(12):993–1001. https://doi.org/10.1016/S2468-1253(21)00301-0; Alsallamin I, Chakhachiro D, Bawwab A, Nassar M, Alsallamin A. Prevalence of Symptomatic Gallbladder Disease After Bariatric Surgery: A Literature Review. Cureus. 2023;15(4):e37777. https://doi.org/10.7759/cureus.37777.; Shiffman ML, Sugerman HJ, Kellum JM, Brewer WH, Moore EW. Gallstone formation after rapid weight loss: A prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity. Am J Gastroenterol. 1991;86:1000–1005. Available at: https://pubmed.ncbi.nlm.nih.gov/1858735.; Östlund MP, Wenger U, Mattsson F, Ebrahim F, Botha A, Lagergren J. Population-based study of the need for cholecystectomy after obesity surgery. BJS. 2012;99:864–869. https://doi.org/10.1002/bjs.8701.; Tsirline VB, Keilani ZM, El Djouzi S, Phillips RC, Kuwada TS, Gersin K et al. How frequently and when do patients undergo cholecystectomy after bariatric surgery? Surg Obes Relat Dis. 2014;10:313–321. https://doi.org/10.1016/j.soard.2013.10.011.; Mazzella G, Bazzoli F, Festi D, Ronchi M, Aldini R, Roda A et al. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Gastroenterology. 1991;101:490–496. https://doi.org/10.1016/0016-5085(91)90029-K.; Reuben A, Qureshi Y, Murphy GM, Dowling RH. Effect of obesity and weight reduction on biliary cholesterol saturation and the response to chenodeoxycholic acid. Eur J Clin Investig. 1986;16:133–142. https://doi.org/10.1111/j.1365-2362.1986.tb01320.x.; Shiffman ML, Shamburek RD, Schwartz CC, Sugerman HJ, Kellum JM, Moore EW. Gallbladder mucin, arachidonic acid, and bile lipids in patients who develop gallstones during weight reduction. Gastroenteroloy. 1993;105:1200–1208. https://doi.org/10.1016/0016-5085(93)90968-I.; Shiffman ML, Sugerman HJ, Kellum JH, Brewer WH, Moore EW. Gallstones in patients with morbid obesity. Relationship to body weight, weight loss and gallbladder bile cholesterol solubility. Int J Obes Relat Metab Disord. 1993;17:153–158. Available at: https://pubmed.ncbi.nlm.nih.gov/8385075.; Haal S, Guman MSS, Acherman YIZ, Jansen JPG, van Weeghel M, van Lenthe H et al. Gallstone Formation Follows a Different Trajectory in Bariatric Patients Compared to Nonbariatric Patients. Metabolites. 2021;11(10):682. https://doi.org/10.3390/metabo11100682.; Bastouly M, Arasaki CH, Grande JC. Corpus Early Changes in Postprandial Gallbladder Emptying in Morbidly Obese Patients Undergoing Roux-en-Y Gastric Bypass: Correlation with the Occurrence of Biliary Sludge and Gallstones. Obesity Surgery. 2009;19:22–28. https://doi.org/10.1007/s11695-008-9648-y.; Fobi M, Lee H, Igwe D, Felahy B, James E, Stanczyk M, Fobi N. Prophylactic cholecystectomy with gastric bypass operation: incidence of gallbladder disease. Obes Surg. 2002;12(3):350–353. https://doi.org/10.1381/096089202321088138.; Boerlage TCC, Haal SL, de Brauw M, Acherman YIZ, Bruin S, van de Laar AWJM et al. Ursodeoxycholic acid for the prevention ofsymptomatic gallstone disease afterbariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial). BMC Gastroenterology. 2017;17:164. https://doi.org/10.1186/s12876-017-0674-x.; Worni M, Guller U, Shah A, Gandhi M, Shah J, Rajgor D et al. Cholecystectomy concomitant with laparoscopic gastric bypass: a trend analysis of the nationwide inpatient sample from 2001 to 2008. Obes Surg. 2012;22(2):220–229. https://doi.org/10.1007/s11695-011-0575-y.; D’Hondt M, Sergeant G, Deylgat B, Devriendt D, Van Rooy F, Vansteenkiste F. Prophylactic cholecystectomy, a mandatory step in morbidly obese patients undergoing laparoscopic roux-en-Y gastric bypass? J Gastrointest Surg. 2011;15(9):1532–1536. https://doi.org/10.1007/s11605-011-1617-4.; Yang H, Petersen GM, Roth MP, Schoenfield LJ, Marks JW. Risk factors for gallstone formation during rapid loss of weight. Dig Dis Sci. 1992;37(6):912–918. https://doi.org/10.1007/BF01300390.; Hempfling W, Dilger K, Beuers U. Systematic review: ursodeoxycholic acid- -adverse effects and drug interactions. Aliment Pharmacol Ther. 2003;18(10):963–972. https://doi.org/10.1046/j.1365-2036.2003.01792.x.; Simental-Mendia LE, Simental-Mendia M, Sanchez-Garcia A, Maciej Banach, Maria-Corina Serban, Arrigo F G Cicero et al. Impact of ursodeoxycholic acid on circulating lipid concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials. Lipids Health Dis. 2019;18(1):88. https://doi.org/10.1186/s12944-019-1041-4.; Kuiper EM, Hansen BE, Lesterhuis W, Robijn RJ, Thijs JC, Engels LG et al. The long-term effect of ursodeoxycholic acid on laboratory liver parameters in biochemically non-advanced primary biliary cirrhosis. Clin Res Hepatol Gastroenterol. 2011;35(1):29–33. https://doi.org/10.1016/j.gcb.2010.07.018.; Hofmann AF. Pharmacology of ursodeoxycholic acid, an enterohepatic drug. Scand J Gastroenterol Suppl. 1994;29(Suppl. 204):1–15. https://doi.org/10.3109/00365529409103618.; Staley C, Weingarden AR, Khoruts A, Michael J Sadowsky. Interaction of gut microbiota with bile acid metabolism and its influence on disease states. Appl Microbiol Biotechnol. 2017;101(1):47–64. https://doi.org/10.1007/s00253-016-8006-6.; Albaugh VL, Banan B, Antoun J, Blake Austin Clements, Naji N. Abumrad, Charles Robb Flynn et al. Role of bile acids and GLP-1 in mediating the metabolic improvements of bariatric surgery. Gastroenterology. 2019;156(4):1041–1051.e4. https://doi.org/10.1053/j.gastro.2018.11.017.; Sahlin S, Ahlberg J, Reihner E, Ståhlberg D, Einarsson K. Cholesterol metabolism in human gallbladder mucosa: relationship to cholesterol gallstone disease and effects of chenodeoxycholic acid and ursodeoxycholic acid treatment. Hepatology. 1992;16(2):320–326. https://doi.org/10.1002/hep.1840160207.; Carotti S, Guarino MPL, Cicala M, G Perrone, R Alloni, F Segreto et al. Effect of ursodeoxycholic acid on inflammatory infiltrate in gallbladder muscle of cholesterol gallstone patients. Neurogastroenterol Motil. 2010;22(8):866-E232. https://doi.org/10.1111/j.1365-2982.2010.01510.x.; Roma MG, Toledo FD, Boaglio AC, Basiglio CL, Crocenzi FA, Sánchez Pozzi EJ. Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications. Clin Sci (Lond). 2011;121(12):523–544. https://doi.org/10.1042/CS20110184.; Marschall HU, Mueller M, Wagner M, Lackner C, Thorell A, Trauner M. 1307 High levels of ursodeoxycholic acid act as FXR antagonist and deplete liver cholesterol due to increased bile acid synthesis in morbidly obese patients. J Hepatol. 2012;56(2):S515. https://doi.org/10.1016/S0168-8278(12)61319-1.; Zhang YJ, Jiang RQ, Zheng XJ, Sha Lei, Fengjie Huang, Guoxiang Xie et al. Ursodeoxycholic acid accelerates bile acid enterohepatic circulation. Brit J Pharmacol. 2019;176(16):2848–2863. https://doi.org/10.1111/bph.14705.; Fearon NM, Kearns EC, Kennedy CA, Conneely JB, Heneghan HM. The impact of ursodeoxycholic acid on gallstone disease after bariatric surgery: a meta-analysis of randomized control trials. Surg Obes Relat Dis. 2022;18(1):77–84. https://doi.org/10.1016/j.soard.2021.10.004.; Uy MC, Talingdan-Te MC, Espinosa WZ, Daez ML, Ong JP. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis. Obes Surg. 2008;18(12):1532–1538. https://doi.org/10.1007/s11695-008-9587-7.; Sugerman HJ, Brewer WH, Shiffman ML, Brolin RE, Fobi MA, Linner JH et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg. 1995;169(1):91–96. https://doi.org/10.1016/S0002-9610(99)80115-9.; Kiewiet RM, Durian MF, van Leersum M, Hesp FL, van Vliet AC. Gallstone formation after weight loss following gastric banding in morbidly obese Dutch patients. Obes Surg. 2006;16(5):592–596. https://doi.org/10.1381/096089206776945020.; Desbeaux A, Hec F, Andrieux S, Fayard A, Bresson R, Pruvot MH, Mulliez E. Risk of biliary complications in bariatric surgery. J Visc Surg. 2010;147(4):e217–e220. https://doi.org/10.1016/j.jviscsurg.2010.08.001.; Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Central adiposity, regional fat distribution, and the risk of cholecystectomy in women. Gut. 2006;55(5):708–714. https://doi.org/10.1136/gut.2005.076133.; Stokes CS, Gluud LL, Casper M, Lammert F. Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta-analysis of randomized controlled trials. Clin Gastroenterol Hepatol. 2014;12(7): 1090–1100.e2; quiz e61. https://doi.org/10.1016/j.cgh.2013.11.031.; Wudel LJJr, Wright JK, Debelak JP, Allos TM, Shyr Y, Chapman WC. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. J Surg Res. 2002;102(1):50–56. https://doi.org/10.1006/jsre.2001.6322.; Abdallah E, Emile SH, Elfeki H, Fikry M, Abdelshafy M, Elshobaky A et al. Role of ursodeoxycholic acid in the prevention of gallstone formation after laparoscopic sleeve gastrectomy. Surg Today. 2017;47(7):844–850. https://doi.org/10.1007/s00595-016-1446-x.; Şen O, Türkçapar AG, Yerdel MA. Cholelithiasis After Sleeve Gastrectomy and Effectiveness of Ursodeoxycholic Acid Treatment. J Laparoendosc Adv Surg Tech A. 2020;30(11):1150–1152. https://doi.org/10.1089/lap.2020.0077.; Mulliri A, Menahem B, Alves A, Dupont B. Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials. J Gastroenterol. 2022;57(8):529–539. https://doi.org/10.1007/s00535-022-01886-4.; Magouliotis DE, Tasiopoulou VS, Svokos AA, Svokos KA, Chatedaki C, Sioka E, Zacharoulis D. Ursodeoxycholic Acid in the Prevention of Gallstone Formation After Bariatric Surgery: an Updated Systematic Review and Meta-analysis. Obes Surg. 2017;27(11):3021–3030. https://doi.org/10.1007/s11695-017-2924-y.; Sharma A, Shanti H, Nageswaran H, Best LMJ, Patel AG. Role of Ursodeoxycholic Acid in the Prevention of Gallstones Formation in Bariatric Patients-a Systematic Review and Meta-Analysis of Randomised Trials. Obes Surg. 2023;33(12):4115–4124. https://doi.org/10.1007/s11695-023-06893-9.; Ying J, Dai S, Fu R, Hong J, Dai C, Jin Q. Effect of ursodeoxycholic acid on gallstone formation after bariatric surgery: An updated meta-analysis. Obesity (Silver Spring). 2022;30(6):1170–1180. https://doi.org/10.1002/oby.23427.; Al-Huniti M, Alsardia Y, Odeh A, Bdour B, Hassanat R, Aloun A et al. Ursodeoxycholic Acid Prophylaxis and the Reduction of Gallstone Formation After Bariatric Surgery: An Updated Meta-Analysis of Randomized Controlled Trials. Cureus. 2023;15(12):e50649. https://doi.org/10.7759/cureus.50649.; Coogan AC, Williams MD, Krishnan V, Skertich NJ, Becerra AZ, Sarran M et al. Ursodiol Prescriptions Following Bariatric Surgery: National Prescribing Trends and Outcomes. Obes Surg. 2023;33(8):2361–2367. https://doi.org/10.1007/s11695-023-06710-3.; Mechanick JI, Apovian C, Brethauer S, Garvey WT, Joffe AM, Kim J et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures – 2019 update: cosponsored by American Association of clinical endocrinologists/American College of endocrinology, the obesity society, American Society for metabolic & bariatric surgery, obesity medicine association, and American Society of anesthesiologists – executive summary. Endocr Pract. 2019;25(12):1346–1359. https://doi.org/10.4158/GL-2019-0406.; Miller AT, Matar R, Abu Dayyeh BK, Beran A, Vela MF, Lacy BE et al. Postobesity Surgery Esophageal Dysfunction: A Combined Cross-Sectional Prevalence Study and Retrospective Analysis. Am J Gastroenterol. 2020;115(10):1669–1680. https://doi.org/10.14309/ajg.0000000000000733.; Минушкин ОН. Рациональная фармакотерапия в современной гастроэнтерологии. Медицинский Совет. 2021;(15):13–18. https://doi.org/10.21518/2079-701X-2021-15-13-18.

الاتاحة: https://www.med-sovet.pro/jour/article/view/8578
https://doi.org/10.21518/ms2024-385

View record in BASE

7

Academic Journal

ЗНАЧЕНИЕ ЛАПАРОЭНДОСКОПИЧЕСКОЙ КОРРЕКЦИИ ХОЛЕДОХОЛИТИАЗА В ЛЕЧЕНИИ БОЛЬНЫХ С ОСЛОЖНЕННЫМИ ФОРМАМИ ЖЕЛЧНОКАМЕННОЙ БОЛЕЗНИ.

المؤلفون: Бобур, МУХИДДИНОВ, Зафар, КУРБАНИЯЗОВ, Пулат, АСКАРОВ

المصدر: 2(3), 31-38, (2024-06-17)

مصطلحات موضوعية: желчнокаменная болезнь, холедохолитиаз, холецистэктомия, холедохолитоэкстракция, папиллосфинктеротомия, техника Rendezvous, лапароэндоскопическое рандеву

Relation: https://doi.org/10.5281/zenodo.12073059; https://doi.org/10.5281/zenodo.12073060; oai:zenodo.org:12073060

الاتاحة: https://doi.org/10.5281/zenodo.12073060

View record in BASE

8

Academic Journal

ХИРУРГИЧЕСКИЙ ЛЕЧЕНИЯ ОСЛОЖНЕННЫХ ФОРМ ЖЕЛЧНОКАМЕННОЙ БОЛЕЗНИ У БОЛЬНЫХ СТАРШЕ 60 ЛЕТ

المؤلفون: Назаров Зокир Норжигитович, Сулаймонов Салим Узганбаевич Самаркандский Государственный медицинский университет, Самарканд, Узбекистан.

المصدر: Research Focus International Scientific Journal, 3(5), (2024-06-06)

مصطلحات موضوعية: Ключевые слова: желчнокаменная болезнь, осложнения, пожилой и старческий возраст

Relation: https://zenodo.org/communities/rf2181-3833; https://doi.org/10.5281/zenodo.11499163; https://doi.org/10.5281/zenodo.11499164; oai:zenodo.org:11499164

الاتاحة: https://doi.org/10.5281/zenodo.11499164

View record in BASE

9

Academic Journal

ЭФФЕКТИВНОСТЬ ИСПОЛЬЗОВАНИЯ МИНИЛАПАРОТОМНОГО ДОСТУПА В ХИРУРГИЧЕСКОМ ЛЕЧЕНИИ БОЛЬНЫХ ЖЕЛЧНОКАМЕННОЙ БОЛЕЗНИ

المؤلفون: Курьязов Б.Н, Бабаджанов А.Р, Рузматов П.Ю, Бабаджанов К.Б.

المصدر: Journal of Universal Science Research, 2(2), 373-381, (2024-02-29)

مصطلحات موضوعية: желчнокаменная болезнь, минилапаротомия, лапароскопия, холецистэктомия

Relation: https://doi.org/10.5281/zenodo.10727607; https://doi.org/10.5281/zenodo.10727608; oai:zenodo.org:10727608

الاتاحة: https://doi.org/10.5281/zenodo.10727608

View record in BASE

10

Academic Journal

Small bowel obstruction with gallstone. Case report ; Редкий случай желчнокаменной обтурационной тонкокишечной непроходимости ; Рідкісний випадок жовчнокам’яної обтураційної тонкокишкової непрохідності

المؤلفون: Braslavets, V. M., Pavlov, K. I., Kulak, O. V., Kolos, Ya. F., Chernov, S. A.

المصدر: Surgery of Ukraine; No. 2 (2018); 74—77 ; Хирургия Украины; № 2 (2018); 74—77 ; Хірургія України; № 2 (2018); 74—77 ; 2521-697X ; 1818-5398

مصطلحات موضوعية: желчнокаменная болезнь, cholelithiasis

وصف الملف: application/pdf

Relation: https://surgukraine.co.ua/article/view/SU2018274/131850; https://surgukraine.co.ua/article/view/SU2018274

الاتاحة: https://surgukraine.co.ua/article/view/SU2018274

View record in BASE

11

Academic Journal

Возможности Применения Одноэтапной Лапароэндоскопической Технологии В Лечении Осложненных Форм Желчнокаменной Болезни

المؤلفون: Азадович, Аскаров Пулат

المصدر: World of Medicine : Journal of Biomedical Sciences; Vol. 1 No. 9 (2024): World of Medicine : Journal of Biomedical Sciences; 69-77 ; 2960-9356

مصطلحات موضوعية: желчнокаменная болезнь, холедохолитиаз, холецистэктомия, холедохолитоэкстракция, папиллосфинктеротомия, техника Rendezvous, лапароэндоскопическое рандеву

وصف الملف: application/pdf

Relation: https://wom.semanticjournals.org/index.php/biomed/article/view/116/94; https://wom.semanticjournals.org/index.php/biomed/article/view/116

الاتاحة: https://wom.semanticjournals.org/index.php/biomed/article/view/116

View record in BASE

12

Academic Journal

ВЫБОР ХИРУРГИЧЕСКОЙ ТАКТИКИ ОСЛОЖНЕННЫХ ФОРМ ЖЕЛЧНОКАМЕННОЙ БОЛЕЗНИ У БОЛЬНЫХ ПОЖИЛОГО И СТАРЧЕСКОГО ВОЗРАСТА

المؤلفون: Назаров Зокир Норжигитович, Сулаймонов Салим Узганбаевич Самаркандский Государственный медицинский университет, Самарканд, Узбекистан.

المصدر: Research Focus International Scientific Journal, 3(5), (2024-06-06)

مصطلحات موضوعية: Ключевые слова: желчнокаменная болезнь, осложнения, пожилой и старческий возраст

Relation: https://zenodo.org/communities/rf2181-3833; https://doi.org/10.5281/zenodo.11499345; https://doi.org/10.5281/zenodo.11499346; oai:zenodo.org:11499346

الاتاحة: https://doi.org/10.5281/zenodo.11499346

View record in BASE

13

Academic Journal

RESULTS OF LAPAROSCOPIC CHOLECYSTECTOMY WITH CORRECTION OF COMBINED SURGICAL PATHOLOGY IN PATIENTS OF ADOLESCENCE AND YOUNG AGE ; РЕЗУЛЬТАТЫ ЛАПАРОСКОПИЧЕСКОЙ ХОЛЕЦИСТЭКТОМИИИ С КОРРЕКЦИЕЙ СОПУТСТВУЮЩЕЙ ХИРУРГИЧЕСКОЙ ПАТОЛОГИИ У ПАЦИЕНТОВ ПОДРОСТКОВОГО И ЮНОШЕСКОГО ВОЗРАСТА. ; O'SMIR VA BALOG’AT YOSHDAGI BEMORLARDA LAPAROSKOPIK XOLESISTEKTOMIYA BILAN HAMROH JARROHLIK PATOLOGIYALARNI DAVOLASH NATIJALARI

المؤلفون: Ходжиматов , Гуломидин, Егитов, Аюбхон

المصدر: International Journal of Scientific Pediatrics; Vol. 3 No. 1 (2024): January; 445-449 ; Международный журнал научной педиатрии; Том 3 № 1 (2024): Январь; 445-449 ; Xalqaro ilmiy pediatriya jurnali; Nashr soni. 3 No. 1 (2024): Yanvar; 445-449 ; 2181-2926

مصطلحات موضوعية: девочки и мальчики подросткового и юношеского возраста, желчнокаменная болезнь, сопутствующая патология, эндовидеохирургическая технология, симультанные операции, girls and boys of adolescence and young age, cholelithiasis, combined pathology, endovideosurgical technology, simultaneous operations, O'smirlik va balog’at yoshdagi qizlar va o'g'il bolalar, o’t tosh kasalligi, hamroh jarrohlik patologiyasi, endovideojarrohlik texnologiyasi, simultan jarrohlik